Is ERAS stock a Buy, Sell, or Hold?

Based on our analysis, ERAS is currently a HOLD with moderate confidence. 📊 HOLD: ERAS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

What is the fair value of ERAS stock?

Our analysis estimates the fair value range for ERAS to be between $11.41 and $14.22. The current price is $15.21.

What is the analyst price target for ERAS?

The average Wall Street analyst price target for ERAS is $21.00. This implies a potential upside of 39.3% from current levels.

ERAS Stock Analysis: Buy, Sell, or Hold?

ERAS - Erasca, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

$15.21

0.13 (0.86%) ▲

5d: +5.41%

30d: +31.06%

90d: +6.22%

HOLD

MODERATE Confidence

Protect Your ERAS Gains

Analysis Updated: Jun 22, 2026 12:00 AM ET

Earnings: Aug 11, 2026

Smart Money Distribution

None View Scanner →

Strength: 7.7/10

Get Alerted When ERAS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: ERAS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ERAS is currently trading at $15.21, which is considered extended relative to its 30-day fair value range of $11.41 to $14.22.

Technical Outlook: Technically, ERAS is showing sideways momentum. The price is approaching resistance at $15.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: ERAS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.00 (+39.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $11.41 - $14.22

Company Quality Score 54/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.9%

Protect Your Profits

Holding ERAS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range (+7.0% above its trading range)
BULLISH: Strong technical setup (60/100)
BULLISH: High volume confirmation
BULLISH: Trading 39.3% below Wall St target ($21.00)

Trading Range Analysis

30-Day Trading Range $11.41 - $14.22

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $12.26

Resistance Level $15.19

Current Trend Sideways

Technical data as of Jun 22, 2026

Fundamental Context

Forward P/E (Next Year Est.) -26.24

Wall Street Target $21.00 (+39.3%)

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: June 23, 2026 12:55 PM ET
Data refreshes hourly during market hours. Next update: 1:55 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is ERAS showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Ebun Garner SELL 80000 shares 2026-04-01

Shannon Morris SELL 20000 shares 2026-03-04

Ebun Garner SELL 120000 shares 2026-01-07

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for ERAS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NTLA Intellia Therapeutics Inc	STRONG BUY 29 analysts	$27	56 HOLD
ARGX argenx NV ADR	STRONG BUY 22 analysts	$1022	64 BUY
ONC BeiGene, Ltd.	STRONG BUY 24 analysts	$412	53 HOLD
INSM Insmed Inc	STRONG BUY 21 analysts	$197	56 HOLD
ACLX Arcellx Inc	STRONG BUY 18 analysts	$113	57 HOLD

NTLA Intellia Therapeu…

Advanced ERAS Option Strategies

Professional options setups generated by AI based on today's ERAS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ERAS

ERAS Technical Chart ERAS Price Prediction ERAS Earnings Date ERAS Investment Advisor ERAS Fair Price Analyzer ERAS Options Advisor ERAS Options Chain ERAS Options Analysis ERAS Competitors

Compare ERAS with Peers

ERAS vs TNGX
Which one to buy?

ERAS vs GLUE
Which one to buy?

ERAS vs EWTX
Which one to buy?

ERAS vs IPSC
Which one to buy?

ERAS vs LYEL
Which one to buy?

ALMS vs ERAS
Winner: ERAS

ERAS vs ACLX

CTMX vs ERAS

Create New Comparison View All Competitors

Tradestie